The pcr and realtime pcr testing market size has grown strongly in recent years. It will grow from $11.12 billion in 2025 to $12.02 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to expansion of molecular diagnostics adoption, increasing prevalence of infectious diseases, growth of genomics research activities, rising use of pcr in clinical diagnostics, expansion of academic research infrastructure.
The pcr and realtime pcr testing market size is expected to see strong growth in the next few years. It will grow to $16.38 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising adoption of digital pcr technologies, expansion of decentralized diagnostic testing, growing investments in life science research, increasing use of pcr in oncology and genetic testing. Major trends in the forecast period include increasing adoption of high-throughput pcr platforms, rising demand for multiplex real-time pcr assays, growing integration of automated sample preparation systems, expansion of digital pcr applications, enhanced focus on contamination-free testing.
The increasing number of approvals for personalized medicines is anticipated to drive the growth of the PCR and real-time PCR testing market in the coming years. Personalized medicines are therapeutic products or treatments customized for individual patients and are developed based on a patient’s genetic, biomarker, phenotypic, or psychosocial characteristics that can influence treatment response. PCR and real-time PCR play a critical role in personalized medicine by enabling accurate identification of genetic variations, which supports the customization of treatments and optimization of therapeutic outcomes. For example, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared to six approvals in 2022. Therefore, the growing approvals for personalized medicines are contributing to the expansion of the PCR and real-time PCR testing market.
Major companies operating in the PCR and real-time PCR testing market are developing highly specific detection kits, including variant-targeted RT-PCR assays, to improve the tracking of viral evolution and support epidemiological surveillance. Variant-targeted RT-PCR assays are molecular diagnostic tests designed to identify specific genetic mutations or variations within a virus, allowing accurate detection of particular viral strains or sub-variants. For example, in January 2023, Roche, a Switzerland-based diagnostics company, launched the VirSNiP SARS-CoV-2 Spike F486P assay, a real-time PCR test that specifically identifies the F486P mutation in the XBB.1.5 Omicron sub-variant. The assay operates on standard real-time PCR platforms such as the LightCycler 480 II and cobas z 480 and provides precise lineage differentiation to support effective variant monitoring.
In February 2025, Bio-Rad Laboratories, a US-based provider of life science research and clinical diagnostics products, acquired Stilla Technologies for an undisclosed amount. Through this acquisition, Bio-Rad intends to incorporate Stilla’s next-generation digital PCR systems into its portfolio to drive innovation in molecular diagnostics across applications including infectious disease testing, oncology, and cell therapy. Stilla Technologies is a US-based developer of all-in-one digital PCR platforms, consumables, and assays designed for high-multiplex and high-throughput molecular testing.
Major companies operating in the pcr and realtime pcr testing market are Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc.
Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2025. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pcr and realtime pcr testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the PCR and real-time PCR testing market by increasing costs of imported thermal cyclers, optical detection systems, reagents, enzymes, plastics, and precision electronic components used in instruments and consumables. Clinical diagnostics laboratories and research institutes in North America and Europe are most affected due to reliance on imported instruments and reagents, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are elevating testing costs and slowing procurement of advanced systems. However, they are also encouraging localized reagent manufacturing, regional instrument assembly, and domestic supply chain development for critical molecular diagnostic components.
The pcr and realtime pcr testing market research report is one of a series of new reports that provides pcr and realtime pcr testing market statistics, including pcr and realtime pcr testing industry global market size, regional shares, competitors with a pcr and realtime pcr testing market share, detailed pcr and realtime pcr testing market segments, market trends and opportunities, and any further data you may need to thrive in the pcr and realtime pcr testing industry. This pcr and realtime pcr testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) tests are widely used techniques for detecting and quantifying DNA (or RNA) in a given sample. These tests are typically carried out in automated thermal cyclers, which are designed to minimize the risk of cross-contamination. PCR and real-time PCR have various applications in fields such as cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays.
The primary products associated with PCR and real-time PCR testing include consumables, reagents, instruments, software, and various services. These tests leverage technologies such as quantitative PCR and digital PCR, which offer a range of applications in clinical diagnostics, life science research, industrial settings, and other fields. The market for PCR and real-time PCR testing is segmented by end-use, which includes academic and research institutes, pharmaceutical and biotechnology companies, clinical diagnostics labs and hospitals, and other entities.
The PCR and Real-time PCR testing market consists of sales of genetic sequencing equipment such as automated thermo cyclers with technologies such as quantitative PCR and digital PCR for cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pcr and realtime pcr testing market size is expected to see strong growth in the next few years. It will grow to $16.38 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising adoption of digital pcr technologies, expansion of decentralized diagnostic testing, growing investments in life science research, increasing use of pcr in oncology and genetic testing. Major trends in the forecast period include increasing adoption of high-throughput pcr platforms, rising demand for multiplex real-time pcr assays, growing integration of automated sample preparation systems, expansion of digital pcr applications, enhanced focus on contamination-free testing.
The increasing number of approvals for personalized medicines is anticipated to drive the growth of the PCR and real-time PCR testing market in the coming years. Personalized medicines are therapeutic products or treatments customized for individual patients and are developed based on a patient’s genetic, biomarker, phenotypic, or psychosocial characteristics that can influence treatment response. PCR and real-time PCR play a critical role in personalized medicine by enabling accurate identification of genetic variations, which supports the customization of treatments and optimization of therapeutic outcomes. For example, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared to six approvals in 2022. Therefore, the growing approvals for personalized medicines are contributing to the expansion of the PCR and real-time PCR testing market.
Major companies operating in the PCR and real-time PCR testing market are developing highly specific detection kits, including variant-targeted RT-PCR assays, to improve the tracking of viral evolution and support epidemiological surveillance. Variant-targeted RT-PCR assays are molecular diagnostic tests designed to identify specific genetic mutations or variations within a virus, allowing accurate detection of particular viral strains or sub-variants. For example, in January 2023, Roche, a Switzerland-based diagnostics company, launched the VirSNiP SARS-CoV-2 Spike F486P assay, a real-time PCR test that specifically identifies the F486P mutation in the XBB.1.5 Omicron sub-variant. The assay operates on standard real-time PCR platforms such as the LightCycler 480 II and cobas z 480 and provides precise lineage differentiation to support effective variant monitoring.
In February 2025, Bio-Rad Laboratories, a US-based provider of life science research and clinical diagnostics products, acquired Stilla Technologies for an undisclosed amount. Through this acquisition, Bio-Rad intends to incorporate Stilla’s next-generation digital PCR systems into its portfolio to drive innovation in molecular diagnostics across applications including infectious disease testing, oncology, and cell therapy. Stilla Technologies is a US-based developer of all-in-one digital PCR platforms, consumables, and assays designed for high-multiplex and high-throughput molecular testing.
Major companies operating in the pcr and realtime pcr testing market are Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc.
Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2025. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pcr and realtime pcr testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the PCR and real-time PCR testing market by increasing costs of imported thermal cyclers, optical detection systems, reagents, enzymes, plastics, and precision electronic components used in instruments and consumables. Clinical diagnostics laboratories and research institutes in North America and Europe are most affected due to reliance on imported instruments and reagents, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are elevating testing costs and slowing procurement of advanced systems. However, they are also encouraging localized reagent manufacturing, regional instrument assembly, and domestic supply chain development for critical molecular diagnostic components.
The pcr and realtime pcr testing market research report is one of a series of new reports that provides pcr and realtime pcr testing market statistics, including pcr and realtime pcr testing industry global market size, regional shares, competitors with a pcr and realtime pcr testing market share, detailed pcr and realtime pcr testing market segments, market trends and opportunities, and any further data you may need to thrive in the pcr and realtime pcr testing industry. This pcr and realtime pcr testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) tests are widely used techniques for detecting and quantifying DNA (or RNA) in a given sample. These tests are typically carried out in automated thermal cyclers, which are designed to minimize the risk of cross-contamination. PCR and real-time PCR have various applications in fields such as cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays.
The primary products associated with PCR and real-time PCR testing include consumables, reagents, instruments, software, and various services. These tests leverage technologies such as quantitative PCR and digital PCR, which offer a range of applications in clinical diagnostics, life science research, industrial settings, and other fields. The market for PCR and real-time PCR testing is segmented by end-use, which includes academic and research institutes, pharmaceutical and biotechnology companies, clinical diagnostics labs and hospitals, and other entities.
The PCR and Real-time PCR testing market consists of sales of genetic sequencing equipment such as automated thermo cyclers with technologies such as quantitative PCR and digital PCR for cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. PCR and Realtime PCR Testing Market Characteristics
3. PCR and Realtime PCR Testing Market Supply Chain Analysis
4. Global PCR and Realtime PCR Testing Market Trends and Strategies
5. PCR and Realtime PCR Testing Market Analysis of End Use Industries
7. Global PCR and Realtime PCR Testing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global PCR and Realtime PCR Testing Total Addressable Market (TAM) Analysis for the Market
9. PCR and Realtime PCR Testing Market Segmentation
10. PCR and Realtime PCR Testing Market Regional and Country Analysis
11. Asia-Pacific PCR and Realtime PCR Testing Market
12. China PCR and Realtime PCR Testing Market
13. India PCR and Realtime PCR Testing Market
14. Japan PCR and Realtime PCR Testing Market
15. Australia PCR and Realtime PCR Testing Market
16. Indonesia PCR and Realtime PCR Testing Market
17. South Korea PCR and Realtime PCR Testing Market
18. Taiwan PCR and Realtime PCR Testing Market
19. South East Asia PCR and Realtime PCR Testing Market
20. Western Europe PCR and Realtime PCR Testing Market
21. UK PCR and Realtime PCR Testing Market
22. Germany PCR and Realtime PCR Testing Market
23. France PCR and Realtime PCR Testing Market
24. Italy PCR and Realtime PCR Testing Market
25. Spain PCR and Realtime PCR Testing Market
26. Eastern Europe PCR and Realtime PCR Testing Market
27. Russia PCR and Realtime PCR Testing Market
28. North America PCR and Realtime PCR Testing Market
29. USA PCR and Realtime PCR Testing Market
30. Canada PCR and Realtime PCR Testing Market
31. South America PCR and Realtime PCR Testing Market
32. Brazil PCR and Realtime PCR Testing Market
33. Middle East PCR and Realtime PCR Testing Market
34. Africa PCR and Realtime PCR Testing Market
36. PCR and Realtime PCR Testing Market Competitive Landscape and Company Profiles
37. PCR and Realtime PCR Testing Market Other Major and Innovative Companies
40. PCR and Realtime PCR Testing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
PCR And Realtime PCR Testing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pcr and realtime pcr testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pcr and realtime pcr testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pcr and realtime pcr testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Consumables And Reagents; Instruments; Software And Services2) By Technology: Quantitative PCR; Digital PCR
3) By Application: Clinical Diagnostics; Life Science Research; Industrial Applications; Other Applications
4) By End-Use: Academic And Research Institutes; Pharmaceutical And Biotechnology; Clinical Diagnostics Labs And Hospitals; Other End Users
Subsegments:
1) By Consumables And Reagents: PCR Reagents; PCR Kits; PCR Primers And Probes; DNA And RNA Extraction Kits2) By Instruments: PCR Machines/Amplifiers; Real-Time PCR Systems; Thermal Cyclers; Automated PCR Systems
3) By Software And Services: Data Analysis Software; PCR Software; Maintenance And Support Services; Training Services
Companies Mentioned: Abbott Laboratories; Agilent Technologies Inc.; bioMérieux SA; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.; QIAGEN N.V.; GenMark Diagnostics Inc.; Thermo Fisher Scientific Inc.; General Electric Company; Danaher Corporation; Becton Dickinson and Company; Luminex Corporation; Meridian Bioscience Inc.; Fluidigm Corporation; RainDance Technologies Inc.; BioFire Diagnostics LLC; Cepheid Inc.; Illumina Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Promega Corporation; Takara Bio Inc.; Twist Bioscience Corporation; Zymo Research Corporation; BioChain Institute Inc.; BioLegend Inc.; Bioo Scientific Corporation; Creative Diagnostics; Eurofins Scientific SE; Myriad Genetics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this PCR and Realtime PCR Testing market report include:- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- GenMark Diagnostics Inc.
- Thermo Fisher Scientific Inc.
- General Electric Company
- Danaher Corporation
- Becton Dickinson and Company
- Luminex Corporation
- Meridian Bioscience Inc.
- Fluidigm Corporation
- RainDance Technologies Inc.
- BioFire Diagnostics LLC
- Cepheid Inc.
- Illumina Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California Inc.
- Promega Corporation
- Takara Bio Inc.
- Twist Bioscience Corporation
- Zymo Research Corporation
- BioChain Institute Inc.
- BioLegend Inc.
- Bioo Scientific Corporation
- Creative Diagnostics
- Eurofins Scientific SE
- Myriad Genetics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.02 Billion |
| Forecasted Market Value ( USD | $ 16.38 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
